Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Johnson & JohnsonJNJ-0.57%said a booster dose of its Covid-19 vaccine ...
网页链接Trial participants in the U.S. who received a second dose eight weeks after the first had 94% protection against the illness. Johnson & JohnsonJNJ-0.57%said a booster dose of its Covid-19 vaccine ...
网页链接
精彩评论